Prothrombin Complex Concentrate Market

Prothrombin Complex Concentrates Market: Shift from Bleeding Disorder Treatment Towards Replacement Therapy to Propel Market Growth: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

  • 2018-12-17
  • REP-GB-7032
  • 223 pages
  • PDF PPT EXCEL
 Prothrombin Complex Concentrate Market

An Incisive, In-depth Analysis on the Prothrombin Complex Concentrate Market

This study offers a comprehensive, 360 degree analysis on the Prothrombin Complex Concentrate market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Prothrombin Complex Concentrate market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Shift from Third Party Plasma Suppliers – Key Strategy

Manufacturers of prothrombin complex concentrates were dependent on third-party suppliers for plasma as a precursor. Presently, manufacturers have shifted focus on establishing their own plasma collection banks in order to cut down their operational costs. For instance, CSL Behring GmbH, a prominent player in the market has increased the number plasma collection centers over the past years, marking their 200th plasma collection center in the U.S. in 2017.

Prothrombin Complex Concentrates Market Witnessing Considerable Growth in China

According to the discussions held with key opinion leaders in the prothrombin complex concentrates market, a substantial growth has been witnessed in the China market for prothrombin complex concentrates. Manufacturers operating in the China & APEC markets are estimated to have significant growth opportunities in the prothrombin complex concentrates market over the forecast period.

Unmet Hemophilia Therapeutic Needs and Growing Geriatric Population

As the requirement of anticoagulation therapy is increasing amongst the geriatric population, the need to reverse anticoagulation in adverse condition is also increasing. Thus, the growing geriatric population is expected to fuel the growth of the prothrombin complex market over the forecast period. The worldwide incidence of hemophilia is not well known, however, it has been estimated that more than 400,000 people have hemophilia. Approximately 75% of people with hemophilia have been estimated to receive inadequate treatment or have no access to treatment.

80% Revenue Contribution by Leading Manufacturers in Prothrombin Complex Concentrates Market

The prothrombin complex concentrates market is mainly dominated by the global manufactures. The manufacturers of prothrombin complex concentrates are competing based on adoption of prothrombin complex concentrates. The growing demand for optimized & sustainable healthcare has create immense growth opportunities for the global manufacturers. Companies such as Shire, Octapharma AG, and CSL Behring GmbH hold approximately 80% revenue share in the global prothrombin complex concentrates market. Also, companies operating in the prothrombin complex concentrates market are collaborating with retailers and local distributors to increase the penetration of prothrombin complex concentrates.

Competitive Landscape

The company’s report titled “Prothrombin Complex Concentrates Market” provides detailed information about the growth parameters of the companies operating in the prothrombin complex concentrates market. It includes detailed assessment of the competitive environment in the prothrombin complex concentrates market. The market study provides comprehensive data on each stakeholder in the prothrombin complex concentrates market, including Shire, Octapharma AG, Nihon Pharmaceutical Co Ltd, Sanquin Blood Supply Foundation, CSL Behring GmbH, Kedrion Biopharma Inc, and Grifols, S.A. The report provides readers with all-encompassing data on each prothrombin complex concentrates manufacturer’s revenue shares, winning strategies, and latest information on key strategies in the prothrombin complex concentrates market.

Definition

Prothrombin concentrates also known as prothrombin complex concentrates (PCC) are medications containing various clotting factors. PCCs are used for treating patients with hemophilia B, and used in those with not enough of these factors due to other reasons such as warfarin therapy.

3-Factor prothrombin complex concentrates are prothrombin concentrates containing factors II, IX, and X. For instance, Uman Complex DI (Grifols Biologicals Inc.). 4-Factor Prothrombin complex concentrates are prothrombin concentrates containing factors II, VII, IX, and X. For instance, Kcentra/Confidex/Beriplex (CSL Behring GmbH).

About the Report

The study on the prothrombin complex concentrates market was recently published by the company, which provides comprehensive information about the most important market dynamics that prove instrumental in the growth of the prothrombin complex concentrates market during 2018-2026. Companies in the prothrombin complex concentrates market can find the most accurate quantitative and qualitative information about the growth parameters of the other prothrombin complex concentrates manufacturers, which can help them develop business strategies in the coming future.

Segmentation

The report on the prothrombin complex concentrates market provides salient information on market players. The prothrombin complex concentrates market is segmented by region, product type, indication, and distribution channel, to analyze segment-wise growth of the prothrombin complex concentrates market. Based on regions, the prothrombin complex concentrates market is segmented into seven regions – North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding China & Japan (APECJ), Japan, China, and the Middle East & Africa (MEA). The prothrombin complex concentrates market by product type is segmented into 3-Factor prothrombin complex concentrates, and 4-factor prothrombin complex concentrates. By indication, the prothrombin complex concentrates market is segregated into hemorrhagic episodes in factor IX defficiency - Haemiohilia B, trauma, life-threatening coagulopathy with acute bleeding, warfarin-associated acute, life threatening bleeding, and non-warfarin anticoagulant reversal with acute bleeding. By distribution channel, the prothrombin complex concentrates market is segregated into compound pharmacies, retail pharmacies, and hospital pharmacies.

Additional Questions Answered

Readers can find detailed information about the important positive and negative factors affecting the prothrombin complex concentrates market during the forecast period. Additionally, the report also contains valuable information that can provide prothrombin complex concentrates manufacturers with answers to critical questions, such as

  • Which types of products account for the maximum demand for prothrombin complex concentrates market? Why is it so?

  • Why is the sale of prothrombin complex concentrates high in North America? What are the factors customers seek in prothrombin complex concentrates?

  • Which factors are influencing the strategies of players in the prothrombin complex concentrates market?

  • What are the current trends adopted by various companies?

  • What are the strategies being applied by the manufacturers in order to sustain themselves in the competitive market?

Research Methodology

The process of market research followed by the company commences with extensive secondary research of the prothrombin complex concentrates market. We have obtained industry-validated, historic, and current data about the demand for prothrombin complex concentrates across the globe. Comprehensive secondary research was followed by extensive and in-depth primary research, where detailed information about the prothrombin complex concentrates market was obtained in terms of value (US$ Million). Based on thorough secondary and primary research of the growth parameters of the prothrombin complex concentrates market, we have come up with the most precise forecast on how the prothrombin complex concentrates market will grow during the forecast period.

A recent market study published by the company titled “Prothrombin Complex Concentrates Market: Global Industry Analysis 2013–2017 & Opportunity Assessment 2018–2028” consists a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the Prothrombin Complex Concentrates market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the Prothrombin Complex Concentrates market during the forecast period. It can help the players to modify their manufacturing and marketing strategies to envisage maximum growth in the Prothrombin Complex Concentrates market in the upcoming years. The report provides detailed information about the current and future growth prospects of the Prothrombin Complex Concentrates market in the most comprehensive way for the better understanding of readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the Prothrombin Complex Concentrates market report, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the Prothrombin Complex Concentrates market.

Chapter 2 – Market Introduction

Readers can find detailed structure and the definition of the Prothrombin Complex Concentrates market in this chapter, which will help readers to understand the basic information about the Prothrombin Complex Concentrates market. This section also considers the factors included and excluded for the purpose of this report.

Chapter 3 – Prothrombin Complex Concentrates Market Opportunity Analysis

Readers can find various macro-economic factors associated with the growth of Prothrombin Complex Concentrates, which would help them track the market current scenario, with key inferences drawn from historical data, current trends, and future prospects. This section also consists of an opportunity analysis conducted for understanding revenue attractiveness of the market.

Chapter 4 – Prothrombin Complex Concentrates Market Background

This chapter highlights the key market dynamics including the drivers, restraints and trends. In this chapter, readers can understand the factors which are propelling the growth of the market along with the factors which may deter the growth of the market. Also readers will understand the key trends followed by the leading manufacturers in the Prothrombin Complex Concentrates market.

Chapter 5 – Prothrombin Complex Concentrates Market: Global Economic Outlook

This section highlights the expenditure on health for top countries in each region. This section also explains the global and regional healthcare market outlook. Regional healthcare market focuses to explain deeply about the political, economic and business environment outlook of the respective region.

Chapter 6 – North America Prothrombin Complex Concentrates Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

This chapter includes detailed analysis of the growth of the North America Prothrombin Complex Concentrates market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on product type, indication, end users, and regions of Prothrombin Complex Concentrates market in the North American region.

Chapter 7 – Latin America Prothrombin Complex Concentrates Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

Readers can find detailed information about factors such as regional trends that are impacting the growth of the Latin America Prothrombin Complex Concentrates market. This chapter also includes the growth prospects of the Prothrombin Complex Concentrates market in leading LATAM countries such as Brazil, Mexico, Argentina, and rest of the Latin America region.

Chapter 8 – Western Europe Prothrombin Complex Concentrates Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

Important growth prospects of the Prothrombin Complex Concentrates market based on its product types and indication in several European countries, such as Germany, France, Italy, Spain, UK, Benelux, Nordics, & Rest of Western Europe are included in this chapter.

Chapter 9 – Eastern Europe Prothrombin Complex Concentrates Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

Important growth prospects of the Prothrombin Complex Concentrates market based on its product types and indication in several European countries, such as Poland, Russia, and Rest of Eastern Europe are included in this chapter.

Chapter 10 – Asia Pacific Excluding China & Japan Prothrombin Complex Concentrates Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

India, ASEAN, Australia & New Zealand and rest of Asia Pacific except China & Japan are the leading countries in the Asian Pacific region that are the prime subject of assessment to obtain growth prospects of the Asia Pacific except China & Japan Prothrombin Complex Concentrates market in this chapter. Readers can find important factors that can have a huge impact on the growth of the Prothrombin Complex Concentrates market in Asia Pacific based on the market segmentation, during the forecast period.

Chapter 11 – Middle East and Africa Prothrombin Complex Concentrates Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

 This chapter provides information on how the Prothrombin Complex Concentrates market will grow in the major countries in MEA region, such as GCC, South Africa and Rest of Middle East and Africa during the period 2013-2028.

Chapter 12 – China Prothrombin Complex Concentrates Market Analysis 2013–2017 & Opportunity Assessment 2018–2028

Readers can find important factors that can make a huge impact on the growth of the Prothrombin Complex Concentrates market in China based on the market segmentation, during the forecast period. This chapter provides the overview of regulations, drivers, restraints, and trends in the China Prothrombin Complex Concentrates market.

Chapter 13 – Japan Prothrombin Complex Concentrates Market Analysis 2013–2017 & Opportunity Assessment 2018–2028

Readers can find important factors that can make a huge impact on the growth of the Prothrombin Complex Concentrates market in Japan based on the market segmentation, during the forecast period. This chapter provides the overview of regulations, drivers, restraints, and trends in the Japan Prothrombin Complex Concentrates market.

Chapter 14 – Competition Landscape, Company Share and Company Profiles

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Prothrombin Complex Concentrates market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Market players featured in the report include Shire, Octapharma AG, NIHON PHARMACEUTICAL CO., LTD, Sanquin Blood Supply Foundation, CSL Behring GmbH, Kedrion Biopharma Inc. Grifols, S.A.

Chapter 15 – Global Prothrombin Complex Concentrates Market Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Region

This chapter explains how the Prothrombin Complex Concentrates market will grow across various geographic regions, such as North America, Latin America, Europe, Asia-Pacific except China and Japan, the Middle East & Africa (MEA), China and Japan.

Chapter 16 – Global Prothrombin Complex Concentrates Market Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Product Type

Based on the product type, the Prothrombin Complex Concentrates market is segmented into 3-Factor Prothrombin Complex Concentrates and 4-Factor Prothrombin Complex Concentrates. In this chapter, readers can find information about key trends and developments in the Prothrombin Complex Concentrates market and market attractive analysis based on the product type. In this chapter, readers can find information about key trends and developments in the Prothrombin Complex Concentrates market and market attractive analysis based on the product type for each region.

Chapter 17 – Global Prothrombin Complex Concentrates Market Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Indication

Based on the indication, the Prothrombin Complex Concentrates market is segmented into Haemorrhagic episodes in Factor IX defficiency - Haemiohilia B, Trauma, Life-Threatening Coagulopathy with Acute Bleeding, Warfarin-Associated Acute, Life Threatening Bleeding and Non-Warfarin Anticoagulant Reversal with Acute Bleeding. In this chapter, readers can find information about key trends and developments in the Prothrombin Complex Concentrates market and market attractive analysis based on indication. In this chapter, readers can find information about key trends and developments in the Prothrombin Complex Concentrates market and market attractive analysis based on the Indication for each region.

Chapter 18 – Global Prothrombin Complex Concentrates Market Analysis 2013–2017 and Opportunity Assessment 2018–2028, By End Users

Based on the end users, the Prothrombin Complex Concentrates market is segmented into Compound Pharmacies, Hospital Pharmacies and Retail Pharmacies. In this chapter, readers can find information about key trends and developments in the Prothrombin Complex Concentrates market and market attractive analysis based on end users. In this chapter, readers can find information about key trends and developments in the Prothrombin Complex Concentrates market and market attractive analysis based on the end users for each region.

Chapter 19 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 20 – Research Methodology

This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the Prothrombin Complex Concentrates market.

Prothrombin Complex Concentrate Market Reports - Table of Contents

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology